Neural Cell News Volume 15.14 | Apr 14 2021

    0
    89







    2021-04-14 | NCN 15.14


    Neural Cell News by STEMCELL Technologies
    Vol. 15.14 – 14 April, 2021
    TOP STORY

    Glioblastomas Acquire Myeloid-Affiliated Transcriptional Programs via Epigenetic Immunoediting to Elicit Immune Evasion

    By serially transplanting glioblastoma multiforme stem cells (GSCs) into immunocompetent hosts, scientists uncovered an acquired capability of GSCs to escape immune clearance by establishing an enhanced immunosuppressive tumor microenvironment.
    [Cell]

    Full ArticleGraphical Abstract

    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    PUBLICATIONSRanked by the impact factor of the journal

    Early Stem Cell Aging in the Mature Brain

    Researchers pinpointed multiple factors that disrupted neural stem cell (NSC) behavior in the adult hippocampus. Clonal tracing showed that NSCs exhibited asynchronous depletion by identifying short-term NSCs and long-term NSCs.
    [Cell Stem Cell]

    AbstractGraphical Abstract

    Astrocytes and Neurons Share Region-Specific Transcriptional Signatures That Confer Regional Identity to Neuronal Reprogramming

    Investigators showed that in the neocortex and thalamus, neurons and astrocytes express shared region-specific transcriptional and epigenetic signatures.
    [Science Advances]

    Full Article

    APOE2 Mitigates Disease-Related Phenotypes in an Isogenic hiPSC-Based Model of Alzheimer’s Disease

    The authors utilized an isogenic human induced pluripotent stem cell (hiPSC)-based system to demonstrate that conversion of APOE3 to APOE2 greatly reduced the production of amyloid-beta peptides in hiPSC-derived neural cultures.
    [Molecular Psychiatry]

    Full Article

    The White Matter Is a Pro-Differentiative Niche for Glioblastoma

    Researchers identified the white matter as a differentiative niche for glioblastomas with oligodendrocyte lineage competency.
    [Nature Communications]

    Full Article

    In Situ Architecture of Neuronal α-Synuclein Inclusions

    Investigators demonstrated that neuronal α-Synuclein (α-Syn) inclusions consisted of α-Syn fibrils intermixed with membranous organelles, and illuminated the mechanism of aggregate seeding and cellular interaction.
    [Nature Communications]

    Full Article

    PI3Kγ Inhibition Suppresses Microglia/TAM Accumulation in Glioblastoma Microenvironment to Promote Exceptional Temozolomide Response

    Glioblastoma-associated microglia/macrophages secreted interleukin 11 activated STAT3-MYC signaling in glioblastoma cells. This signaling induced stem cell states that conferred enhanced tumorigenicity and resistance to the standard-of-care chemotherapy, temozolomide.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Brd4-Bound Enhancers Drive Cell-Intrinsic Sex Differences in Glioblastoma

    Researchers discovered correlated transcriptome-wide sex differences in gene expression, H3K27ac marks, large Brd4-bound enhancer usage, and Brd4 localization to Myc and p53 genomic binding sites. These sex-biased gene expression patterns were also evident in human glioblastoma stem cells.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    Neural Stem Cells Traffic Functional Mitochondria via Extracellular Vesicles

    The authors investigated the hypothesis that neural stem cells release and traffic functional mitochondria via extracellular vesicles to restore mitochondrial function in target cells.
    [PLoS Biology]

    Full Article

    C3G Downregulation Induces the Acquisition of a Mesenchymal Phenotype That Enhances Aggressiveness of Glioblastoma Cells

    Investigators report that C3G downregulation promoted the acquisition of a more mesenchymal phenotype that enhanced the migratory and invasive capacity of glioblastoma cells.
    [Cell Death & Disease]

    Full Article

    Mutation-Specific Non-Canonical Pathway of PTEN as a Distinct Therapeutic Target for Glioblastoma

    Researchers established a library of cancer cell lines that overexpressed mutant proteins using the U87MG and patient-derived cell models lacking functional PTEN.
    [Cell Death & Disease]

    Full Article


    Her 'mini-brains' creation was unexpected. Her protocol was groundbreaking. Watch Madeline Lancaster's webinar.
    REVIEWS

    Astrocytes in Cocaine Addiction and Beyond

    Scientists provide a brief overview of the role of astrocytes in regulating synaptic transmission and neuronal function and discuss how cocaine influences these astrocyte-mediated mechanisms to induce persistent synaptic and circuit alterations that promote cocaine seeking and relapse.
    [Molecular Psychiatry]

    Abstract

    Targeting Innate Immunity to Protect and Cure Alzheimer’s Disease: Opportunities and Pitfalls

    The authors present both sides of the story with a particular emphasis on the beneficial properties of innate immune cells and how they can be targeted to have neuroprotective properties.
    [Molecular Psychiatry]

    Abstract

    WDR45, One Gene Associated with Multiple Neurodevelopmental Disorders

    Investigators summarize the current knowledge about the cellular and physiological functions of WDR45 and highlight how genetic variants in its encoding gene may contribute to the pathophysiology of the associated diseases.
    [Autophagy]

    Full Article

    INDUSTRY AND POLICY NEWS

    Otsuka and Lundbeck Announce Decision to Continue Phase III Clinical Trial Evaluating Brexpiprazole for Treatment of Agitation in Patients with Alzheimer’s-Type Dementia

    Otsuka Pharmaceutical Co., Ltd and H. Lundbeck A/S has announced the decision to continue the recruitment of patients in the Phase III clinical trial of brexpiprazole in the treatment of agitation in patients with dementia of the Alzheimer’s type.
    [Otsuka Pharmaceutical Co., Ltd]

    Press Release

    MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson’s Disease and Expands Pipeline to Aging

    MedRhythms has announced the initiation of a multi-site clinical trial, in collaboration with Boston University, of its pipeline asset MR-005 in Parkinson’s disease as well as the expansion of the company’s pipeline into aging with the development of its Aging Scientific Advisory Board.
    [MedRhythms (Cision US Inc.)]

    Press Release

    Treovir Announces Positive Results of Phase I Study of G207 in Pediatric Patients with Recurrent High-Grade Glioma

    Treovir, LLC has announced that G207, an oncolytic HSV immunotherapy, was well tolerated with evidence of clinical effectiveness in a Phase I study of 12 pediatric patients with recurrent high-grade glioma.
    [Treovir, LLC (Cision US Inc.)]

    Press Release

    FEATURED EVENT

    NeuroFrance 2021

    May 19 – May 21, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Training Fellow – Neuronal Presynaptic Function

    Francis Crick Institute – London, England. United Kingdom

    Postdoctoral Positions – Neurodegenerative Diseases

    Johns Hopkins University School of Medicine – Baltimore, Maryland, United States

    Research Fellow – Translational Neurobiology

    Duke-NUS Medical School – Singapore, Singapore

    Researcher Positions – Glucose Homeostasis

    Rutgers University – New Brunswick, New Jersey, United States

    Postdoctoral Fellow – Systems Neuroscience

    NIH National Institute on Aging – Baltimore, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Neural Cell News Twitter